• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JAMA Pediatr . Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany

tetano

Editor, Senior Moderator
JAMA Pediatr


. 2021 Jan 22.
doi: 10.1001/jamapediatrics.2021.0001. Online ahead of print.
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany


Burkhard T?nshoff[SUP] 1 [/SUP], Barbara M?ller[SUP] 2 [/SUP], Roland Elling[SUP] 3 4 [/SUP], Hanna Renk[SUP] 5 [/SUP], Peter Meissner[SUP] 6 [/SUP], Hartmut Hengel[SUP] 7 [/SUP], Sven F Garbade[SUP] 1 [/SUP], Meinhard Kieser[SUP] 8 [/SUP], Kathrin Jeltsch[SUP] 1 [/SUP], J?rgen Grulich-Henn[SUP] 1 [/SUP], Julia Euler[SUP] 1 [/SUP], Maximilian Stich[SUP] 1 [/SUP], Kristine Chobanyan-J?rgens[SUP] 1 9 10 [/SUP], Maria Zernickel[SUP] 6 [/SUP], Aleš Janda[SUP] 6 [/SUP], Lena W?lfle[SUP] 6 [/SUP], Thomas Stamminger[SUP] 11 [/SUP], Thomas Iftner[SUP] 12 [/SUP], Tina Ganzenmueller[SUP] 12 [/SUP], Christian Schmitt[SUP] 3 [/SUP], Tessa G?rne[SUP] 3 [/SUP], Vibor Laketa[SUP] 2 [/SUP], Sylvia Olberg[SUP] 2 [/SUP], Anna Plaszczyca[SUP] 13 [/SUP], Mirko Cortese[SUP] 13 [/SUP], Ralf Bartenschlager[SUP] 13 [/SUP], Constantin Pape[SUP] 14 15 [/SUP], Roman Remme[SUP] 14 [/SUP], Daniela Huzly[SUP] 7 [/SUP], Marcus Panning[SUP] 7 [/SUP], Sebastian Weigang[SUP] 7 [/SUP], Sebastian Giese[SUP] 7 [/SUP], Kevin Ciminski[SUP] 7 [/SUP], Jakob Ankerhold[SUP] 7 [/SUP], Georg Kochs[SUP] 7 [/SUP], Martin Schwemmle[SUP] 7 [/SUP], Rupert Handgretinger[SUP] 5 [/SUP], Charlotte M Niemeyer[SUP] 3 [/SUP], Corinna Engel[SUP] 16 [/SUP], Winfried V Kern[SUP] 17 [/SUP], Georg Friedrich Hoffmann[SUP] 1 [/SUP], Axel R Franz[SUP] 16 [/SUP], Philipp Henneke[SUP] 3 4 [/SUP], Klaus-Michael Debatin[SUP] 6 [/SUP], Hans-Georg Kr?usslich[SUP] 2 [/SUP]



Affiliations

Abstract

Importance: School and daycare closures were enforced as measures to confine the novel coronavirus disease 2019 (COVID-19) pandemic, based on the assumption that young children may play a key role in severe acute respiratory coronavirus 2 (SARS-CoV-2) spread. Given the grave consequences of contact restrictions for children, a better understanding of their contribution to the COVID-19 pandemic is of great importance.
Objective: To describe the rate of SARS-CoV-2 infections and the seroprevalence of SARS-CoV-2 antibodies in children aged 1 to 10 years, compared with a corresponding parent of each child, in a population-based sample.
Design, setting, and participants: This large-scale, multicenter, cross-sectional investigation (the COVID-19 BaW? study) enrolled children aged 1 to 10 years and a corresponding parent between April 22 and May 15, 2020, in southwest Germany.
Exposures: Potential exposure to SARS-CoV-2.
Main outcomes and measures: The main outcomes were infection and seroprevalence of SARS-CoV-2. Participants were tested for SARS-CoV-2 RNA from nasopharyngeal swabs by reverse transcription-polymerase chain reaction and SARS-CoV-2 specific IgG antibodies in serum by enzyme-linked immunosorbent assays and immunofluorescence tests. Discordant results were clarified by electrochemiluminescence immunoassays, a second enzyme-linked immunosorbent assay, or an in-house Luminex-based assay.
Results: This study included 4964 participants: 2482 children (median age, 6 [range, 1-10] years; 1265 boys [51.0%]) and 2482 parents (median age, 40 [range, 23-66] years; 615 men [24.8%]). Two participants (0.04%) tested positive for SARS-CoV-2 RNA. The estimated SARS-CoV-2 seroprevalence was low in parents (1.8% [95% CI, 1.2-2.4%]) and 3-fold lower in children (0.6% [95% CI, 0.3-1.0%]). Among 56 families with at least 1 child or parent with seropositivity, the combination of a parent with seropositivity and a corresponding child with seronegativity was 4.3 (95% CI, 1.19-15.52) times higher than the combination of a parent who was seronegative and a corresponding child with seropositivity. We observed virus-neutralizing activity for 66 of 70 IgG-positive serum samples (94.3%).
Conclusions and relevance: In this cross-sectional study, the spread of SARS-CoV-2 infection during a period of lockdown in southwest Germany was particularly low in children aged 1 to 10 years. Accordingly, it is unlikely that children have boosted the pandemic. This SARS-CoV-2 prevalence study, which appears to be the largest focusing on children, is instructive for how ad hoc mass testing provides the basis for rational political decision-making in a pandemic.
 
Back
Top Bottom